The FTC’s legal fight against three major pharmacy benefit managers is on hold after two agency commissioners have been ...
Eli Lilly’s direct-to-consumer service added knownwell to its line-up of providers who can prescribe its medications, as it ...
BIO CEO John Crowley sat down for an exclusive interview that covered tariffs, collaborating with RFK Jr., and investing in ...
Tang Capital’s shell company Concentra Biosciences secured its first major deal since late 2023. Allakos has agreed ...
Edgewise Therapeutics' EDG-7500 shows positive Phase 2 results in heart muscle disease trial, reducing LVOT-G by up to 71%.
Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...
Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal ...
The size and scope of the FDA that began Tuesday won’t be the same as the day nears a brutal conclusion for agency staffers ...
Eli Lilly's RNA drug solbinsiran reduced ApoB protein levels by 14.3% in Phase 2 cholesterol trial, competing with ...
The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” clinical data, which would likely cut the cost of entry into the market.
Atsena Therapeutics raises $150M Series C, led by Bain Capital Life Sciences, to advance ATSN-201 gene therapy for X-linked retinoschisis through FDA application.
The HHS and other federal agencies must reverse the terminations of probationary government workers that were fired in the states challenging the cuts, under a new order issued Tuesday by a federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback